New pill trial aims to slow deadly brain Cancer's return
NCT ID NCT05326464
Summary
This study is testing whether a pill called Tofacitinib can slow down the growth of glioblastoma, a very aggressive brain cancer, when it comes back after initial treatment. It involves 17 adults with recurrent cancer who will take the pills daily in 28-day cycles. Doctors will use regular brain scans to see if the treatment delays tumor progression and is safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
Conditions
Explore the condition pages connected to this study.